Cosomil

Cosomil is a biotech company in Tokyo, Japan, founded in 2022. It has 2 recorded funding rounds, most recently an Extension Round in February 2026.

Single-molecule enzyme activity-based liquid biopsy for early disease detection

Headquarters
Tokyo
Employees
11–50
Founded
2022
Business Model
B2B
Last Round
Extension RoundFeb 2026
Rounds
2

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Cosomil, Inc. (コウソミル株式会社) is a Japanese biotech startup developing single-molecule enzyme activity-based liquid biopsy technology for early disease detection and drug development support. Founded in 2022 and headquartered at the University of Tokyo's entrepreneurship lab, Cosomil uses proprietary fluorescent enzyme substrates and microdevices to measure enzyme activity at the single-molecule level with ultra-high sensitivity. Their primary application is early detection of pancreatic cancer through blood tests. The company operates two business lines: early diagnostic drug development and pharmaceutical development support. Backed by investors including ANRI, Delight Ventures, and Coral Capital, Cosomil raised a Series A1 round in February 2026 to accelerate cancer screening blood test implementation in Japan and the US.

Summary

It lists 11–50 employees. Its most recent funding was an Extension Round in Feb 2026. Investors include Delight Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundSeries A1Feb 2026

Sign up to see all 2 events

Funding: Venture Round through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cosomil on Indexed.vc
<a href="https://indexed.vc/companies/cosomil"><img src="https://indexed.vc/api/badge/company/cosomil" alt="Cosomil on Indexed.vc" width="260" height="76" /></a>